Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo

Oncogene

Volumn 24, Issue 51, 2005, Pages 7624-7629

  Javelaud, Delphine ^a   Delmas, Véronique ^b   Möller, Maria ^a   Sextius, Peggy ^a   André, Jocelyne ^a   Menashi, Suzanne ^a   Larue, Lionel ^b   Mauviel, Alain ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT CURIE   (France)

Author keywords

Angiogenesis; Melanoma; Metalloproteinases; Smad; TGF ; Tumor progression

Indexed keywords

COLLAGEN; GELATIN; GELATINASE A; GELATINASE B; LAMININ; MATRIGEL; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOGENICITY; CELL ADHESION; CELL CLONE; CELL MIGRATION; CELL MOTILITY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEASUREMENT; MELANOMA; MELANOMA CELL; METASTASIS; NUDE MOUSE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSACTIVATION; TUMOR CELL; ZYMOGRAPHY;

ANIMALS; CELL ADHESION; CELL MOVEMENT; GENE EXPRESSION PROFILING; HUMANS; MATRIX METALLOPROTEINASE 9; MELANOMA; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 27844514155     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208900     Document Type: Article

References (23)

1. Akhurst RJ and Derynck R. (2001). Trends Cell. Biol., 11, S44-S51.
2. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D. (2000). Nat. Cell. Biol., 2, 737-744.
3. Berking C, Takemoto R, Schaider H, Showe L, Satyamoorthy K, Robbins P and Herlyn M. (2001). Cancer Res., 61, 8306-8316.
4. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH and Leof EB. (2004). J. Clin. Invest., 114, 1308-1316.
5. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S and Gauthier JM. (1998). EMBO J., 17, 3091-3100.
6. Gold LI. (1999). Crit. Rev. Oncog., 10, 303-360.
7. Hofmann UB, Westphal JR, Van Muijen GN and Ruiter DJ. (2000). J. Invest. Dermatol., 115, 337-344.
8. Javelaud D, Laboureau J, Gabison E, Verrecchia F and Mauviel A. (2003). J. Biol. Chem., 278, 24624-24628.
9. Javelaud D and Mauviel A. (2004). Int. J. Biochem. Cell. Biol., 36, 1161-1165.
10. Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K and Miyazawa K. (2004). Oncogene, 23, 6914-6923.
11. Ludwig T, Ossig R, Graessel S, Wilhelmi M, Oberleithner H and Schneider SW. (2002). Am. J. Physiol. Renal. Physiol., 283, F319-27.
12. MacDougall J, R, Kobayashi H and Kerbel RS. (1993). Mol. Cell. Diff., 1, 21-40.
13. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH and ten Dijke P. (1997). Nature, 389, 631-635.
14. Nakao A, Okumura K and Ogawa H. (2002). Trends Mol. Med., 8, 361-363.
15. Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D and Medrano EE. (2001). Cancer Res., 61, 8074-8078.
16. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C and Kari C. (1994). Cancer Res., 54, 575-581.
17. Rodeck U, Nishiyama T and Mauviel A. (1999). Cancer Res., 59, 547-550.
18. Shi W, Sun C, He B, Xiong W, Shi X, Yao D and Cao X. (2004). J. Cell. Biol., 164, 291-300.
19. Shi Y and Massague J. (2003). Cell., 113, 685-700.
20. Siegel PM and Massague J. (2003). Nat. Rev. Cancer, 3, 807-821.
21. Stamenkovic I. (2000). Semin. Cancer Biol., 10, 415-433.
22. Wakefield LM and Roberts AB. (2002). Curr. Opin. Genet. Dev., 12, 22-29.
23. Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S, Sowers A, Mitchell JB, Roberts AB and Russo A. (2004). J. Biol. Chem., 279, 15167-15176.